Evidence map›Paper›PMID 29746147›Full record

ReviewAmerican journal of respiratory and critical care medicine2018

Female Sex and Gender in Lung/Sleep Health and Disease. Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung Disease.

MeiLan K Han, Emilio Arteaga-Solis, John Blenis, Ghada Bourjeily, Deborah J Clegg, Dawn DeMeo, Jeanne Duffy, Ben Gaston, Nicola M Heller, Anna Hemnes and 17 more

2 registry-linked trialsAbstract readReview
In one paragraph

Review in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05623059 phase1 / phase2completednot on this mapstarted 2023, after this paper: background citation

Phase IIa Clinical Trial to Evaluate Pharmacokinetics and Safety of Slow Release DHEA

TypeinterventionalSponsorIndiana UniversityRan2023 to 2025Enrolled18ConditionsAsthma, GenotypeArmsSlow Release DHEA
NCT07179952 phase2not yet recruitingnot on this mapstarted 2027, after this paper: background citation

A Study to Evaluate Efficacy and Safety of Slow Release DHEA

TypeinterventionalSponsorIndiana UniversityRan2027 to 2028Enrolled30ConditionsAsthmaArmsSlow Release DHEA, Placebo
3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Sex Differences in Exercise-Induced Bronchoconstriction in Athletes: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2020
    Pooled it
  2. Trial
  3. Article
  4. Sex Differences in Lung Immunity.Immunological reviews · 2026
    Review
  5. Article
  6. Article
  7. Sex, hormones, and lung health.Physiological reviews · 2026
    Review
  8. Estrogen and glucocorticoid receptors co-regulate acrolein-induced respiratory and systemic homeostatic stress responses.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Neuroendocrine contribution to sex-related variations in adverse air pollution health effects.Journal of toxicology and environmental health. Part B, Critical reviews · 2024
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

MeiLan K Han1 Division of Pulmonary and Critical Care, University of Michigan, Ann Arbor, Michigan.
Emilio Arteaga-Solis2 Division of Pediatric Pulmonology, Columbia University Medical Center, New York, New York.
John Blenis3 Pharmacology Ph.D. Program, Sandra and Edward Meyer Cancer Center, New York, New York.
Ghada Bourjeily4 Department of Medicine, Brown University, Providence, Rhode Island.
Deborah J Clegg5 Department of Medicine, University of California Los Angeles, Los Angeles, California.
Dawn DeMeo6 Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Jeanne Duffy7 Department of Medicine and.
Ben Gaston9 Pediatric Pulmonology, Case Western Reserve University, Cleveland, Ohio.
Nicola M Heller10 Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University, Baltimore, Maryland.
Anna Hemnes11 Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Elizabeth Petri Henske12 Division of Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, Massachusetts.
Raksha Jain13 Division of Pulmonary and Critical Care, University of Texas Southwestern Medical Center, Dallas, Texas.
Tim Lahm14 Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, Indiana.
Lisa H Lancaster15 Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Joyce Lee16 Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado, Denver, Colorado.
Marianne J Legato17 Department of Medicine, Columbia University, New York, New York.
Sherry McKee18 Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
Reena Mehra19 Neurologic Institute, Cleveland Clinic, Cleveland, Ohio.
Alison Morris20 Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Y S Prakash21 Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, Minnesota.
Martin R Stampfli22 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada.
Rashmi Gopal-Srivastava23 Office of Rare Diseases Research, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland.
Aaron D Laposky24 Division of Lung Diseases, NHLBI/NIH, Bethesda, Maryland; and.
Antonello Punturieri24 Division of Lung Diseases, NHLBI/NIH, Bethesda, Maryland; and.
Lora Reineck24 Division of Lung Diseases, NHLBI/NIH, Bethesda, Maryland; and.
Xenia Tigno24 Division of Lung Diseases, NHLBI/NIH, Bethesda, Maryland; and.
Janine Clayton25 Office of Research on Women's Health, NIH-Office of the Director, Bethesda, Maryland.

Funding

Sex Hormones in Pulmonary Arterial HypertensionP01HL108800 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI NEWMAN, JOHN HUGHES · 2012 to 2021
$22.0M
NEURAL REGULATION OF AIRWAYS DURING POSTNATAL MATURATIONR01HL056470 · NHLBI · MAYO CLINIC ROCHESTER · PI PRAKASH, Y. S. · 1996 to 2025
$10.5M
Yale SCOR on Gender-Sensitive Treatment for Tobacco DependenceP50DA033945 · NIDA · YALE UNIVERSITY · PI MCKEE, SHERRY ANN · 2012 to 2017
$6.5M
Placental role in mediating adverse outcomes in obstructive sleep apneaR01HD078515 · NICHD · MIRIAM HOSPITAL · PI BOURJEILY, GHADA · 2014 to 2018
$2.7M
Predictors of de novo development of obstructive sleep apnea in pregnancyR01HL130702 · NHLBI · MIRIAM HOSPITAL · PI BOURJEILY, GHADA · 2016 to 2020
$2.6M
Sex differences in macrophage differentiation in allergic lung inflammationR01HL124477 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI HELLER, NICOLA M · 2014 to 2018
$2.0M
Defining Pathways in COPD Patient Oriented ResearchK24HL138188 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MeiLan K Han · 2017 to 2026
$1.2M
Mechanisms of right ventricle adaptation to pulmonary hypertensionR56HL134736 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI LAHM, TIM · 2017 to 2017
$615k
Hypoxia-mediated protective estrogen receptor signaling in pulmonary hypertensionI01BX002042 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI Tim Lahm · 2014 to 2026
–
BLRD VA I01 BX002042NHLBI NIH HHS K24 HL138188NHLBI NIH HHS P01 HL108800NHLBI NIH HHS R01 HL056470NHLBI NIH HHS R01 HL124477NHLBI NIH HHS R01 HL130702NHLBI NIH HHS R56 HL134736NICHD NIH HHS R01 HD078515NIDA NIH HHS P50 DA033945
6 · The paper itself

Abstract

Female sex/gender is an undercharacterized variable in studies related to lung development and disease. Notwithstanding, many aspects of lung and sleep biology and pathobiology are impacted by female sex and female reproductive transitions. These may manifest as differential gene expression or peculiar organ development. Some conditions are more prevalent in women, such as asthma and insomnia, or, in the case of lymphangioleiomyomatosis, are seen almost exclusively in women. In other diseases, presentation differs, such as the higher frequency of exacerbations experienced by women with chronic obstructive pulmonary disease or greater cardiac morbidity among women with sleep-disordered breathing. Recent advances in -omics and behavioral science provide an opportunity to specifically address sex-based differences and explore research needs and opportunities that will elucidate biochemical pathways, thus enabling more targeted/personalized therapies. To explore the status of and opportunities for research in this area, the NHLBI, in partnership with the NIH Office of Research on Women's Health and the Office of Rare Diseases Research, convened a workshop of investigators in Bethesda, Maryland on September 18 and 19, 2017. At the workshop, the participants reviewed the current understanding of the biological, behavioral, and clinical implications of female sex and gender on lung and sleep health and disease, and formulated recommendations that address research gaps, with a view to achieving better health outcomes through more precise management of female patients with nonneoplastic lung disease. This report summarizes those discussions.

Indexed as

Women's HealthAdultAgedAsthmaBehaviorComprehensionDisease ManagementEducationFemaleHumansLung DiseasesMiddle AgedNational Heart, Lung, and Blood Institute (U.S.)Pulmonary Disease, Chronic ObstructiveRisk AssessmentSeverity of Illness Indexlung disorderssex/gendersleep disorders

Identifiers

PMID29746147
PMCPMC6173069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.